Table 1 (abstract P008). Predictors of sustained clinical remission
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Predictor, OR (95% CI) | JADAS criteria | Wallace criteria |
|---|---|---|
≥2 years sustained remission | ||
 JADAS LDA at 3 months* | 4.0 (1.5; 10.6); p=0.005 | 6.1 (1.0; 36.4); p=0.047 |
 Prorated number of active joints ≤1 | 4.8 (1.1; 21.4); p=0.038 | – |
 Wallace remission at 3 months* | – | 51.3 (3.0; 884.2); p=0.007 |
 CHAQ score >0.75 | – | 12.8 (1.2; 137.4); p=0.035 |
 Baseline MTX use | – | 23.1 (1.0; 510.9); p=0.047 |
≥5 years sustained remission | ||
 Age at disease onset ≤0.41 years | 48.5 (2.2; 1082.4); p=0.014 | 110.0 (3.7; 3295.1); p=0.007 |
 Wallace remission at 3 months* | 9.7 (1.2; 76.5); p=0.031 | – |